Fertility Preservation: Emerging Technologies and Clinical Applications

425 Pages·2012·7.25 MB·English

by  William Murk BSc

Fertility Preservation
wwwwwwwwwwwwww
(cid:37)(cid:77)(cid:82)(cid:69)(cid:0)(cid:51)(cid:69)(cid:76)(cid:73)(cid:0) (cid:115)(cid:0) (cid:33)(cid:83)(cid:72)(cid:79)(cid:75)(cid:0)(cid:33)(cid:71)(cid:65)(cid:82)(cid:87)(cid:65)(cid:76)
Editors
Fertility Preservation
(cid:37)(cid:77)(cid:69)(cid:82)(cid:71)(cid:73)(cid:78)(cid:71)(cid:0)(cid:52)(cid:69)(cid:67)(cid:72)(cid:78)(cid:79)(cid:76)(cid:79)(cid:71)(cid:73)(cid:69)(cid:83)(cid:0)
(cid:65)(cid:78)(cid:68)(cid:0)(cid:35)(cid:76)(cid:73)(cid:78)(cid:73)(cid:67)(cid:65)(cid:76)(cid:0)(cid:33)(cid:80)(cid:80)(cid:76)(cid:73)(cid:67)(cid:65)(cid:84)(cid:73)(cid:79)(cid:78)(cid:83)
(cid:38)(cid:79)(cid:82)(cid:69)(cid:87)(cid:79)(cid:82)(cid:68)(cid:0)(cid:66)(cid:89)(cid:0)(cid:35)(cid:72)(cid:65)(cid:82)(cid:76)(cid:69)(cid:83)(cid:0)(cid:42)(cid:14)(cid:0)(cid:44)(cid:79)(cid:67)(cid:75)(cid:87)(cid:79)(cid:79)(cid:68)(cid:12)(cid:0)(cid:45)(cid:36)
Editors
Emre Seli, MD Ashok Agarwal, PhD,
Department of Obstetrics, HCLD (ABB), EMB (ACE)
Gynecology, and Reproductive Sciences Director
Yale University School of Medicine Center for Reproductive Medicine
New Haven, CT, USA Cleveland Clinic
[email protected] Cleveland, OH, USA
[email protected]
ISBN 978-1-4419-1782-9 e-ISBN 978-1-4419-1783-6
DOI 10.1007/978-1-4419-1783-6
Springer New York Dordrecht Heidelberg London
Library of Congress Control Number: 2011936522
© Springer Science+Business Media, LLC 2012
All rights reserved. This work may not be translated or copied in whole or in part without the
written permission of the publisher (Springer Science+Business Media, LLC, 233 Spring
Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or
scholarly analysis. Use in connection with any form of information storage and retrieval,
electronic adaptation, computer software, or by similar or dissimilar methodology now
known or hereafter developed is forbidden.
The use in this publication of trade names, trademarks, service marks, and similar terms, even if
they are not identified as such, is not to be taken as an expression of opinion as to whether or not
they are subject to proprietary rights.
While the advice and information in this book are believed to be true and accurate at the date
of going to press, neither the authors nor the editors nor the publisher can accept any legal
responsibility for any errors or omissions that may be made. The publisher makes no warranty,
express or implied, with respect to the material contained herein.
Printed on acid-free paper
Springer is part of Springer Science+Business Media (www.springer.com)
Foreword
Women diagnosed with cancer prior to or during their reproductive period
often face both the uncertainty of long-term survival, and the risk of treat-
ment-induced infertility. Treatments for common cancers occurring in
younger women often necessitate extirpation of their reproductive organs,
radiation therapy, and/or chemotherapy, each of which may partially or com-
pletely impair reproductive (and endocrine) function. Fortunately, during the
last two decades, cancer survival in the USA has improved. This has resulted
in an increased focus on maximizing the quality of life for cancer survivors.
Preserving future fertility is a crucial component of the quality of life in pre-
pubertal and reproductive age women. Similarly, cancer can also strike young
men, the treatments for which pose comparable risks to future fertility. Thus,
clinicians caring for such patients will find this textbook valuable in both
counseling and caring for younger women and men with newly diagnosed
cancers.
However, there is a third group of patients in whom fertility preservation
is of increasing relevance, interest, and importance. Women in much of the
industrial world have been progressively delaying initiation/completion of
childbearing to later in life. More women in their late 30s and early 40s are
attempting to conceive for the first time than ever before. Since the incidence
of most cancers in the reproductive age group is comparatively low, inten-
tionally postponing childbearing presents a far more common indication for
fertility preservation than cancer.
The editors are well suited to the purposes of this text. Both are gifted
fertility practitioners and physician scientists. Dr. Ashok Agarwal is the
Director of the Center for Reproductive Medicine at Cleveland Clinic. He has
authored over 150 peer reviewed publications, garnered multiple research
grants, and is internationally recognized for his outstanding contributions in
scientific and clinical aspects of reproductive medicine. Dr. Emre Seli is an
accomplished reproductive scientist and physician at the Yale School of
Medicine. Dr. Seli has conducted novel and potentially landmark research
regarding basic oocyte mRNA processing, a process relevant to maternal age-
associated infertility. Dr. Seli has also pioneered the development of novel
technologies for assessing embryo quality in vitro. Meanwhile, Dr. Seli
directs a highly successful oocyte donation program at his home institution.
Drs. Agarwal and Seli have assembled an “All Star” cast of authors, each
an expert in the topics about which they write. The goal of the text is to pres-
v
vi (cid:38)(cid:79)(cid:82)(cid:69)(cid:87)(cid:79)(cid:82)(cid:68)
ent strategies for fertility preservation in women and men who require gonad-
otoxic and other fertility-impairing therapies. In addition, key epidemiologic,
ethical, medico-legal, psychologic and social aspects of fertility preservation
are discussed. A format that combines a concise scientific background with
practical methodological information, including detailed and straightforward
algorithms, is utilized. Step-by-step protocols for laboratory procedures are
presented. The result is a concise, readable, and highly practical reference
guide for reproductive endocrinologists, embryologists, reproductive scien-
tists, and oncologists. This text will also greatly aid the general ob/gyn in
counseling both the relatively uncommon younger patient facing fertility-
compromising treatments and the increasingly common woman in her 30s or
early 40s who elects to delay fertility for a myriad of professional and per-
sonal reasons. For all these reasons, I can enthusiastically recommend this
textbook to you.
New Haven, CT Charles J. Lockwood, MD
Preface
Dum spiro, spero [As long as I breathe, I hope]
Marcus Tullius Cicero
Cancer is not uncommon in men and women of reproductive age. In the USA
alone, over 130,000 men and women below the age of 45 were afflicted with
cancer in 2008. The compromised fertility that will be faced by many of these
patients can result in significant psychosocial stress and in reduced quality of
life; even long after the cancer has been successfully treated.
Fortunately, the rapid pace of scientific and technological discovery has
increased the options available to men and women in need of fertility preser-
vation. More than 30 years after the birth of the first child conceived by
assisted reproductive technologies, we are now able to cryopreserve embryos,
spermatozoa, and oocytes as well as testicular and ovarian tissue. In addition,
the effect of gonadotoxic treatments on fertility is better defined and the use
of medical interventions for fertility preservation is within reach. With
increasingly complex modalities available for fertility preservation comes the
need for a clear, concise, readable, and practical text to serve as a resource for
healthcare providers.
This textbook has been written with the aim of providing an update on
options for fertility preservation for both men and women. Within this con-
text, this text reviews current therapeutic modalities in great detail and
describes the biologic basis for available interventions. A key aspect of this
volume is the valuable contributions from oncologists, obstetricians, psy-
chologists, epidemiologists, and ethicists in addition to reproductive scien-
tists and infertility specialists. This thorough resource thus recapitulates the
multidisciplinary approach that is required to adequately provide patient care
with a view to fertility preservation.
Following introductory chapters on the epidemiology and ethics of fertil-
ity preservation, this book is divided into two main sections that share a simi-
lar overall format while reviewing fertility preservation in female and then
male patients. Each section starts with a chapter reviewing the gender-
specific biology of the reproductive system within the context of fertility
preservation. Then, the impact of gonadotoxic treatment on gonadal function
and on the offspring is reviewed. Additional chapters in each section sum-
marize established and experimental methodologies currently available for
fertility preservation in both sexes, providing detailed protocols for laboratory
vii
viii (cid:48)(cid:82)(cid:69)(cid:70)(cid:65)(cid:67)(cid:69)
procedures. The resulting comprehensive text provides cutting edge science
and evidence-based suggestions regarding potential interventions directed at
fertility preservation.
This book is dedicated to our patients who, despite facing potentially lethal
diagnoses and compromised quality of life, continue to hope, to live, and to
pursue their dreams of parenthood.
New Haven, CT Emre Seli
Cleveland, OH Ashok Agarwal
Contents
Part I Overview of Fertility Preservation: Epidemiologic,
Social, Ethical, and Medicolegal Aspects
1 The Epidemiology of Fertility Preservation .............................. 3
William Murk and Emre Seli
2 Ethical Discussions in Approaching Fertility
Preservation .................................................................................. 19
Pasquale Patrizio
Part II Fertility Preservation in Women
3 Ovarian Follicle Development and Fertility
Preservation .................................................................................. 29
Yuichi Niikura and Joshua Johnson
4 Impact of Chemotherapy and Radiotherapy
on the Ovary ................................................................................. 45
Maya L. Kriseman and Ertug Kovanci
5 Impact of Chemotherapy and Radiotherapy
on the Uterus ................................................................................ 57
Abbie L. Fields, Deleep Kumar Gudipudi,
and Giuseppe Del Priore
6 Ovarian Transposition ................................................................. 71
Elena S. Ratner, Dan-Arin Silasi, and Masoud Azodi
7 Embryo Cryopreservation and Alternative Controlled
Ovarian Hyperstimulation Strategies for Fertility
Preservation .................................................................................. 77
Bulent Urman, Ozgur Oktem, and Basak Balaban
8 Oocyte Cryopreservation ............................................................. 89
Andrea Borini and Veronica Bianchi
9 Ovarian Tissue Cryopreservation
and Autotransplantation ............................................................. 107
Mohamed A. Bedaiwy, Gihan M. Bareh,
Katherine J. Rodewald, and William W. Hurd
ix